Sponsor content

Smart drug reprofiling

Using a unique combination of computational chemistry, pharmacology and cheminformatics methods, Re-Pharm is successfully reprofiling marketed compounds as early stage candidates ready for partnering. To download the full article, please sign in.

Go to the profile of Re-Pharm
Nov 10, 2015
1
Page of
Go to the profile of Re-Pharm

Re-Pharm

Re-Pharm is an early-stage drug discovery and development company based on the principles of compound re-profiling. Our goal is to identify compounds currently on the market, or previously failed to make it to market for commercial reasons, and re-purpose them to address diseases in areas of unmet medical need.

Comments are disabled